BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Cash on Hand 2022–2025
BioXcel Therapeutics, Inc. annual cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- BioXcel Therapeutics, Inc. cash on hand as of December 31, 2025: 28.4M, a 4.82% decrease year-over-year.
- BioXcel Therapeutics, Inc. cash on hand for 2025 were 28.4M, a 4.82% decrease from 2024.
- BioXcel Therapeutics, Inc. cash on hand for 2024 were 29.9M, a 54.23% decrease from 2023.
- BioXcel Therapeutics, Inc. cash on hand for 2023 were 65.2M, a 66.33% decrease from 2022.
- BioXcel Therapeutics, Inc. cash on hand for 2022 were 193.7M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BioXcel Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $28 |
| 2024 | $30 |
| 2023 | $65 |
| 2022 | $194 |
BioXcel Therapeutics, Inc. Cash on Hand — FAQ
BioXcel Therapeutics, Inc. (BTAI) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's cash on hand history?
The chart and table above show BioXcel Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.